Thomas Egelhoff , Ph.D.

Thomas Egelhoff , Ph.D.

Interim Chairman

  • Department of Cell Biology (NC10)
  • Cleveland Clinic Lerner Research Institute
  • 9500 Euclid Avenue
  • Cleveland, Ohio 44195
  • (216) 445-9912
  • (216) 444-9404

Research interest

We study the regulation of cytoskeletal force production during processes such as cell migration and 3D tissue invasion. Cell migration towards factors such as growth hormones (chemotaxis) plays a central role in a wide variety of processes, ranging from metastatic behavior of cancer cells, to neutrophil homing during infections, to keratinocyte migration during skin wound healing.

We focus on “myosin II” a cytoskeletal force-producing enzyme that has critical roles in both cell migration and cell division. Our long-term goals are to identify the regulatory mechanisms that control this enzyme, and to learn ways to manipulate this machinery in live cells and tissues with the goal of better clinical control of cancer progression and skin wound healing. For these projects we work with human breast cancer cell lines, and in our skin wound healing studies we work with primary human keratinocytes and mouse skin models. We use cell imaging, biochemistry, protein structure function approaches, and siRNA methods for these studies.

In other words ...

The Egelhoff lab studies the mechanical structures inside cells that drive cell migration.  "Nanoscopic" scaffold-like structures in cells assemble, disassemble, and relocalize continuosly as cell migrate, and these structures produce force to help cells squeeze through tight spaces.  Our studies have demonstrated that abundance of these  scaffold structures is strongly increased when cancer cells become metastatic, and in skin cells during wound healing.  In both cases, the increased abundance of these proteins drives invasive cell migration.  We seek to understand how cells upregulate expression of these proteins- in the case of metastasis, our studies could potentially lead to new ways to block cancer metastasis.  In the case of skin wound healing, we may ultimately be able to enhance wound healing by manpulation of these scaffolding structures.

Investigators

  • James F Crish Ph.D.
  • Project Staff
  • Location:NC1-145
  • crishj@ccf.org
  • (216) 445-9913
  • Lucila Licate
  • Principal Technologist
  • Location:NC1-145
  • licatel@ccf.org
  • (216) 445-9913
  • (216) 444-9404
  • Vandana Rai PhD
  • Fellow
  • Location:NC1-145
  • raiv@ccf.org
  • (216) 445-9913
  • (216) 444-9404
  • Dustin Thomas
  • Graduate Student
  • Location:NC1-145
  • thomasd17@ccf.org
  • (216) 445-9913
  • (216) 444-9404

Highlighted Publications

Myosin II Isoform Switching Mediates Invasiveness following TGFβ-induced Epithelial-Mesenchymal Transition.  Beach, J.R., George S. Hussey, G.S., Miller, T.E., Chaudhury,A., Patel, P., Monslow,J., Zheng,Q., Keri, R.A., Reizes, O., Bresnick, A.R., Howe, P.H., Egelhoff, T.T.  PNAS.  108:17991-6, 2011.  

Role of B regulatory subunits of PP2A in myosin II assembly control in Dictyostelium discoideum.  Rai, V. and Egelhoff, T. T.  Eukaryotic Cell, 10:604-610, 2011.  

A proteomic study of myosin II motor proteins during tumor cell migration.  Betapudi, V., Gokulrangan, G., Chance, M.R., and Egelhoff, T.T.  Journal of Molecular Biology, 407:673-686, 2011 

A microfluidic imaging chamber for the direct observation of chemotactic transmigration.  Breckenridge, M.T., Egelhoff, T.T., and Baskaran, H. Biomedical Microdevicies, 12:543-53.  2010. 

Search PubMed for articles by Dr. Egelhoff